SCHEMBL4451787

SCHEMBL4451787

O=C(Nc1ccccc1-n1ccnn1)N[C@H]1[C@@H]2CN(c3ccc(F)cc3F)C[C@@H]21

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HCRTR1 O43613 5/20 0.40
GAA P10253 2/20 0.39
MEN1 O00255 1/20 0.39
ALDH1A1 P00352 1/20 0.39
KMT2A Q03164 1/20 0.39
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
POLB P06746 1/20 0.39
HCRTR2 O43614 1/20 0.38
DRD2 P14416 1/20 0.38
ADRA1D P25100 1/20 0.38
ADRA1A P35348 1/20 0.38
ADRA1B P35368 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.37
HTT P42858 2/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
PKM P14618 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
EPHX2 P34913 1/20 0.36
P2RY1 P47900 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13783801 1.00 HCRTR1 (0.40) HCRTR1GAAMEN1ALDH1A1KMT2A
SCHEMBL4451792 1.00 HCRTR1 (0.40) HCRTR1GAAMEN1ALDH1A1KMT2A
SCHEMBL4455078 0.89 ALDH1A1 (0.44) HCRTR1GAAMEN1ALDH1A1KMT2A
SCHEMBL13783891 0.89 ALDH1A1 (0.44) HCRTR1GAAMEN1ALDH1A1KMT2A
SCHEMBL13783960 0.85 NPC1 (0.41) HCRTR1GAAMEN1ALDH1A1KMT2A
SCHEMBL4460557 0.84 KMT2A (0.52) HCRTR1GAAMEN1ALDH1A1KMT2A
SCHEMBL4460551 0.84 KMT2A (0.52) HCRTR1GAAMEN1ALDH1A1KMT2A
SCHEMBL13783932 0.83 KEAP1 (0.45) HCRTR1GAAMEN1ALDH1A1KMT2A
SCHEMBL4316894 0.83 NPSR1 (0.56) GAAALDH1A1KMT2ANPC1RAB9A
SCHEMBL4316889 0.83 NPSR1 (0.56) GAAALDH1A1KMT2ANPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009090548-A2 3-AZABICYCLO [3.1.0] HEXANE DERIVATIVES AS VANILLOID RECEPTOR LIGANDS GLENMARK PHARMACEUTICALS, S.A. (US) 2009-07-23 WO disclosed